Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
(6E,10E)-geranyllinalool + [reduced NADPH-hemoprotein reductase] + O2 = (3E,7E)-4,8,12-trimethyltrideca-1,3,7,11-tetraene + [oxidized NADPH-hemoprotein reductase] + but-3-en-2-one + 2 H2O
(6E,10E)-geranyllinalool + [reduced NADPH-hemoprotein reductase] + O2 = (3E,7E)-4,8,12-trimethyltrideca-1,3,7,11-tetraene + [oxidized NADPH-hemoprotein reductase] + but-3-en-2-one + 2 H2O

-
-
-
-
(6E,10E)-geranyllinalool + [reduced NADPH-hemoprotein reductase] + O2 = (3E,7E)-4,8,12-trimethyltrideca-1,3,7,11-tetraene + [oxidized NADPH-hemoprotein reductase] + but-3-en-2-one + 2 H2O
the exact mechanism of enzyme is not yet determined. It is possible that CYP82G1 may promote the direct transformation of (E,E)-geranyllinalool and (3R,6E)-nerolidol to (E,E)-4,8,12-trimethyltrideca-1,3,7,11-tetraene and (3E)-4,8-dimethylnona-1,3,7-triene, respectively, with the concomitant release of but-1-en-3-one. But it is also possible that a two-step conversion occurs that includes the formation of intermediate compounds C18 (E,E)-farnesylacetone (from (E,E)-4,8,12-trimethyltrideca-1,3,7,11-tetraene) and C13 (E)-geranylacetone (from (3E)-4,8-dimethylnona-1,3,7-triene). A C4-cleavage product (but-1-en-3-one) resulting from the breakdown of (E,E)-geranyllinalool or (E)-nerolidol is not observed, neither in vitro nor in vivo, and none of the previously proposed ketone intermediates, C18-farnesylacetone and C13-geranylacetone, are detected
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
(3S)-(E,E)-geranyllinalool + [reduced NADPH-hemoprotein reductase] + O2
(E,E)-4,8,12-trimethyltrideca-1,3,7,11-tetraene + but-1-en-3-one + [oxidized NADPH-hemoprotein reductase] + 2 H2O
(3S,6E)-nerolidol + [reduced NADPH-hemoprotein reductase] + O2
(3E)-4,8-dimethylnona-1,3,7-triene + but-1-en-3-one + [oxidized NADPH-hemoprotein reductase] + 2 H2O
(6E,10E)-geranyllinalool + [reduced NADPH-hemoprotein reductase] + O2
(3E,7E)-4,8,12-trimethyltrideca-1,3,7,11-tetraene + [oxidized NADPH-hemoprotein reductase] + but-3-en-2-one + 2 H2O
(E)-nerolidol + [reduced NADPH-hemoprotein reductase] + O2
4,8-dimethylnona-1,3,7-triene + but-1-en-3-one + [oxidized NADPH-hemoprotein reductase] + 2 H2O
-
-
-
-
?
(E,E)-geranyllinalool + [reduced NADPH-hemoprotein reductase] + O2
(E,E)-4,8,12-trimethyltrideca-1,3,7,11-tetraene + but-1-en-3-one + [oxidized NADPH-hemoprotein reductase] + 2 H2O
-
-
-
-
?
arabidiol + [reduced NADPH-hemoprotein reductase] + O2
(3E)-4,8-dimethylnona-1,3,7-triene + ? + [oxidized NADPH-hemoprotein reductase] + 2 H2O
-
-
-
?
additional information
?
-
(3S)-(E,E)-geranyllinalool + [reduced NADPH-hemoprotein reductase] + O2

(E,E)-4,8,12-trimethyltrideca-1,3,7,11-tetraene + but-1-en-3-one + [oxidized NADPH-hemoprotein reductase] + 2 H2O
-
-
-
?
(3S)-(E,E)-geranyllinalool + [reduced NADPH-hemoprotein reductase] + O2
(E,E)-4,8,12-trimethyltrideca-1,3,7,11-tetraene + but-1-en-3-one + [oxidized NADPH-hemoprotein reductase] + 2 H2O
-
-
-
?
(3S)-(E,E)-geranyllinalool + [reduced NADPH-hemoprotein reductase] + O2
(E,E)-4,8,12-trimethyltrideca-1,3,7,11-tetraene + but-1-en-3-one + [oxidized NADPH-hemoprotein reductase] + 2 H2O
biosynthesis of the volatile organic compound (E,E)-4,8,12-trimethyltrideca-1,3,7,11-tetraene
-
-
?
(3S)-(E,E)-geranyllinalool + [reduced NADPH-hemoprotein reductase] + O2
(E,E)-4,8,12-trimethyltrideca-1,3,7,11-tetraene + but-1-en-3-one + [oxidized NADPH-hemoprotein reductase] + 2 H2O
major substrate
-
-
?
(3S)-(E,E)-geranyllinalool + [reduced NADPH-hemoprotein reductase] + O2
(E,E)-4,8,12-trimethyltrideca-1,3,7,11-tetraene + but-1-en-3-one + [oxidized NADPH-hemoprotein reductase] + 2 H2O
B6ST66, B8A110
-
-
-
?
(3S,6E)-nerolidol + [reduced NADPH-hemoprotein reductase] + O2

(3E)-4,8-dimethylnona-1,3,7-triene + but-1-en-3-one + [oxidized NADPH-hemoprotein reductase] + 2 H2O
-
-
-
?
(3S,6E)-nerolidol + [reduced NADPH-hemoprotein reductase] + O2
(3E)-4,8-dimethylnona-1,3,7-triene + but-1-en-3-one + [oxidized NADPH-hemoprotein reductase] + 2 H2O
-
-
-
?
(3S,6E)-nerolidol + [reduced NADPH-hemoprotein reductase] + O2
(3E)-4,8-dimethylnona-1,3,7-triene + but-1-en-3-one + [oxidized NADPH-hemoprotein reductase] + 2 H2O
in vitro activity is 5.3fold higher than with (E,E)-geranyllinalool. (3E)-4,8-dimethylnona-1,3,7-triene is not emitted from Arabidopsis leaves (or only in negligible amounts according to our analysis) because of the absence of a prominent (E)-nerolidol synthase activity in this tissue
-
-
?
(3S,6E)-nerolidol + [reduced NADPH-hemoprotein reductase] + O2
(3E)-4,8-dimethylnona-1,3,7-triene + but-1-en-3-one + [oxidized NADPH-hemoprotein reductase] + 2 H2O
B6ST66, B8A110
-
-
-
?
(3S,6E)-nerolidol + [reduced NADPH-hemoprotein reductase] + O2
(3E)-4,8-dimethylnona-1,3,7-triene + but-1-en-3-one + [oxidized NADPH-hemoprotein reductase] + 2 H2O
B6ST66, B8A110
major substrate
-
-
?
(6E,10E)-geranyllinalool + [reduced NADPH-hemoprotein reductase] + O2

(3E,7E)-4,8,12-trimethyltrideca-1,3,7,11-tetraene + [oxidized NADPH-hemoprotein reductase] + but-3-en-2-one + 2 H2O
-
-
-
?
(6E,10E)-geranyllinalool + [reduced NADPH-hemoprotein reductase] + O2
(3E,7E)-4,8,12-trimethyltrideca-1,3,7,11-tetraene + [oxidized NADPH-hemoprotein reductase] + but-3-en-2-one + 2 H2O
B6ST66, B8A110
-
-
-
?
additional information

?
-
no activity with isophytol, (E)-geraniol, linalool, 3,7,11-trimethyl-3-dodecanol, (Z)-nerolidol. Less than 1% of the activity with (3S,6E)-nerolidol: (E,E,E)-geranylgeraniol, (E,E)-farnesylacetone, (E,E)-farnesol, (E)-geranylacetone. Construction of a protein model based on multiple mammalian P450 templates with closest sequence similarity. Subsequent molecular docking confirms a position of (E)-nerolidol and (E,E)-geranyllinalool in the active site cavity that allows the suggested oxidative bond cleavage reaction to proceed by a syn-elimination (beta-elimination) mechanism. In particular, the carbonyl oxygen of Thr313 in one of the substrate recognition sites appears to be essential for anchoring the substrates by forming a strong hydrogen bond with the hydroxyl group at C3. The model supported the observed differences in substrate specificities
-
-
?
additional information
?
-
cytochrome P450 monooxygenase with narrow substrate specificity for (E,E)-geranyllinalool and (E)-nerolidol. Mechanism follows oxidative bond cleavage of the alcohol substrate via syn-elimination of the polar head, together with an allylic C-5 hydrogen atom. No substrate: racemic linalool or (R)-(-)-linalool
-
-
?
additional information
?
-
-
linalool, (Z)-nerolidol, the primary terpene alcohols (E,E,E)-geranylgeraniol, (E,E)-farnesol, and (E)-geraniol, or fully saturated analogs of (E)-nerolidol and (E,E)-geranyllinalool (3,7,11-trimethyl-3-dodecanol, isophytol) are no functional substrates of the CYP82G1 enzyme
-
-
?
additional information
?
-
-
CYP705A1 cleaves the prenyl side chain of arabidiol to produce (E)-4,8-dimethyl-1,3,7-nonatriene, DMNT, and a nonvolatile C19-ketone derivative
-
-
?
additional information
?
-
CYP705A1 cleaves the prenyl side chain of arabidiol to produce (E)-4,8-dimethyl-1,3,7-nonatriene, DMNT, and a nonvolatile C19-ketone derivative
-
-
?
additional information
?
-
-
no substrate: linalool
-
-
?
additional information
?
-
B6ST66
no substrate: linalool
-
-
?
additional information
?
-
B8A110
no substrate: linalool
-
-
?
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
(3S)-(E,E)-geranyllinalool + [reduced NADPH-hemoprotein reductase] + O2
(E,E)-4,8,12-trimethyltrideca-1,3,7,11-tetraene + but-1-en-3-one + [oxidized NADPH-hemoprotein reductase] + 2 H2O
(3S,6E)-nerolidol + [reduced NADPH-hemoprotein reductase] + O2
(3E)-4,8-dimethylnona-1,3,7-triene + but-1-en-3-one + [oxidized NADPH-hemoprotein reductase] + 2 H2O
(E)-nerolidol + [reduced NADPH-hemoprotein reductase] + O2
4,8-dimethylnona-1,3,7-triene + but-1-en-3-one + [oxidized NADPH-hemoprotein reductase] + 2 H2O
-
-
-
-
?
(E,E)-geranyllinalool + [reduced NADPH-hemoprotein reductase] + O2
(E,E)-4,8,12-trimethyltrideca-1,3,7,11-tetraene + but-1-en-3-one + [oxidized NADPH-hemoprotein reductase] + 2 H2O
-
-
-
-
?
arabidiol + [reduced NADPH-hemoprotein reductase] + O2
(3E)-4,8-dimethylnona-1,3,7-triene + ? + [oxidized NADPH-hemoprotein reductase] + 2 H2O
-
-
-
?
additional information
?
-
(3S)-(E,E)-geranyllinalool + [reduced NADPH-hemoprotein reductase] + O2

(E,E)-4,8,12-trimethyltrideca-1,3,7,11-tetraene + but-1-en-3-one + [oxidized NADPH-hemoprotein reductase] + 2 H2O
-
-
-
?
(3S)-(E,E)-geranyllinalool + [reduced NADPH-hemoprotein reductase] + O2
(E,E)-4,8,12-trimethyltrideca-1,3,7,11-tetraene + but-1-en-3-one + [oxidized NADPH-hemoprotein reductase] + 2 H2O
-
-
-
?
(3S)-(E,E)-geranyllinalool + [reduced NADPH-hemoprotein reductase] + O2
(E,E)-4,8,12-trimethyltrideca-1,3,7,11-tetraene + but-1-en-3-one + [oxidized NADPH-hemoprotein reductase] + 2 H2O
biosynthesis of the volatile organic compound (E,E)-4,8,12-trimethyltrideca-1,3,7,11-tetraene
-
-
?
(3S)-(E,E)-geranyllinalool + [reduced NADPH-hemoprotein reductase] + O2
(E,E)-4,8,12-trimethyltrideca-1,3,7,11-tetraene + but-1-en-3-one + [oxidized NADPH-hemoprotein reductase] + 2 H2O
B6ST66, B8A110
-
-
-
?
(3S,6E)-nerolidol + [reduced NADPH-hemoprotein reductase] + O2

(3E)-4,8-dimethylnona-1,3,7-triene + but-1-en-3-one + [oxidized NADPH-hemoprotein reductase] + 2 H2O
in vitro activity is 5.3fold higher than with (E,E)-geranyllinalool. (3E)-4,8-dimethylnona-1,3,7-triene is not emitted from Arabidopsis leaves (or only in negligible amounts according to our analysis) because of the absence of a prominent (E)-nerolidol synthase activity in this tissue
-
-
?
(3S,6E)-nerolidol + [reduced NADPH-hemoprotein reductase] + O2
(3E)-4,8-dimethylnona-1,3,7-triene + but-1-en-3-one + [oxidized NADPH-hemoprotein reductase] + 2 H2O
B6ST66, B8A110
-
-
-
?
additional information

?
-
-
linalool, (Z)-nerolidol, the primary terpene alcohols (E,E,E)-geranylgeraniol, (E,E)-farnesol, and (E)-geraniol, or fully saturated analogs of (E)-nerolidol and (E,E)-geranyllinalool (3,7,11-trimethyl-3-dodecanol, isophytol) are no functional substrates of the CYP82G1 enzyme
-
-
?
additional information
?
-
-
CYP705A1 cleaves the prenyl side chain of arabidiol to produce (E)-4,8-dimethyl-1,3,7-nonatriene, DMNT, and a nonvolatile C19-ketone derivative
-
-
?
additional information
?
-
CYP705A1 cleaves the prenyl side chain of arabidiol to produce (E)-4,8-dimethyl-1,3,7-nonatriene, DMNT, and a nonvolatile C19-ketone derivative
-
-
?
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
evolution

CYP705A1 is a member of the Brassicaceae-specific CYP705 family
evolution
B6ST66, B8A110
the DMNT biosynthetic pathway and both (DMNT and TMTT) monooxygenases are distinct from those previously characterized for (E)-4,8-dimethyl-1,3,7-nonatriene, DMNT, and (E,E)-4,8,12-trimethyltrideca-1,3,7,11-tetraene, TMTT, synthesis in Arabidopsis thaliana, suggesting independent evolution of these enzymatic activities. The amino acid identity between the maize and Arabidopsis enzymes is below 30%
malfunction

CYP82G1 gene knockout plants do not produce (E,E)-4,8,12-trimethyltrideca-1,3,7,11-tetraene and their phenotype is complemented by the constitutive expression of CYP82G1
malfunction
the null mutant cyp82g1-1 is not impaired in root-specific DMNT biosynthesis, indicating that enzyme Cyp82g1 is not involved in the formation of DMNT in Arabidopsis thaliana roots
metabolism

enzyme CYP705A1 is involved in DMNT biosynthesis in Arabidopsis thaliana roots. The formation of (E)-4,8-dimethyl-1,3,7-nonatriene, DMNT, and (E,E)-4,8,12-trimethyl-1,3,7,11-tridecatetraene, TMTT, in leaf or flower tissues usually occurs by the oxidative breakdown of (E)-nerolidol or (E,E)-geranyl linalool. Arabidiol Is the precursor in DMNT biosynthesis in Arabidopsis thaliana roots, it can be degraded by CYP705A1 to a C19 ketone product (14-apo-arabidiol). Role of the DMNT biosynthetic pathway in resistance against Pythium irregulare
metabolism
B6ST66, B8A110
the C11 homoterpene (E)-4,8-dimethyl-1,3,7-nonatriene (DMNT) is formed by the oxidative degradation of (E)-nerolidol. (E,E)-4,8,12-Trimethyltrideca-1,3,7,11-tetraene (TMTT) is produced via oxidative degradation of (E,E)-geranyllinalool. The first step of both pathways, the formation of the tertiary terpene alcohols (E,E)-geranyllinalool and (E)-nerolidol, is catalyzed by the terpene synthase, TPS2, whereas the subsequent oxidative degradation to DMNT and TMTT is catalyzed by two specific P450 monooxygenases, CYP92C5 and CYP92C6. Pathway mapping of 26 parent lines of US-NAM population for pathways and enzymes contributing to volatile terpene biosynthesis in maize leaves. TPS2 is the regulatory key enzyme
physiological function

enzyme CYP82G1 produces (3E)-4,8-dimethylnona-1,3,7-triene, DMNT, and (E,E)-4,8,12-trimethyltrideca-1,3,7,11-tetraene, TMTT, in vitro but functions as a TMTT synthase in planta because of the presence of (E,E)-geranyllinalool but not of (E)-nerolidol in Arabidopsis thaliana leaves
physiological function
B6ST66, B8A110
gene disruption of CYP92C5 results in loss of (3E)-4,8-dimethylnona-1,3,7-triene production and reduced levels of (3E,7E)-4,8,12-trimethyltrideca-1,3,7,11-tetraene after simulated herbivory. In planta (3E)-4,8-dimethylnona-1,3,7-triene is primarily produced by isoform CYP92C5, whereas the majority of (3E,7E)-4,8,12-trimethyltrideca-1,3,7,11-tetraene is produced by cytochrome P450 monooxygenase, CYP92C6
physiological function
while Arabidopsis thaliana and other angiosperms are known to produce the homoterpene (E)-4,8-dimethyl-1,3,7-nonatriene, DMNT, or its C16-analogue (E,E)-4,8,12-trimethyl-1,3,7,11-tridecatetraene, TMTT, by the breakdown of sesquiterpene and diterpene tertiary alcohols in aboveground tissues, Arabidopsis thaliana roots biosynthesize DMNT by the degradation of the C30 triterpene diol, arabidiol. The reaction is catalyzed by the Brassicaceae-specific cytochrome P450 monooxygenase CYP705A1. In volatile terpene biosynthesis, irregular homo/norterpenes can arise from different biosynthetic routes in a tissue-specific manner. DMNT negatively affects pathogen Pythium irregulare oospore germination and growth
physiological function
B6ST66, B8A110
while enzyme CYP92C5 converts (E)-nerolidol and (E,E)-geranyllinalool to (3E)-4,8-dimethyl-1,3,7,-nonatriene (DMNT) and (E,E)-4,8,12-trimethyltrideca-1,3,7,11-tetraene, respectively, enzyme CYP92C6 only converts (E,E)-geranyllinalool to (E,E)-4,8,12-trimethyltrideca-1,3,7,11-tetraene, TMTT. (E)-4,8-Dimethyl-1,3,7-nonatriene, DMNT, and (E,E)-4,8,12-trimethyltrideca-1,3,7,11-tetraene, TMTT, are volatile homoterpenes. Many such volatiles are assigned functions in the defense against pathogens like lepidopteran larvae, aphids, fungi,and bacteria. Maize volatiles released after herbivore damage display high levels of quantitative and qualitative variation. In planta, DMNT is primarily produced by CYP92C5, whereas the majority of TMTT is produced by a related cytochrome P450 monooxygenase, CYP92C6, which is specific for the conversion of (E,E)-geranyllinalool to TMTT
physiological function
B6ST66, B8A110
while enzyme CYP92C5 converts (E)-nerolidol and (E,E)-geranyllinalool to DMNT and (E,E)-4,8,12-trimethyltrideca-1,3,7,11-tetraene, respectively, enzyme CYP92C6 only converts (E,E)-geranyllinalool to (E,E)-4,8,12-trimethyltrideca-1,3,7,11-tetraene, TMTT. (E)-4,8-Dimethyl-1,3,7-nonatriene, DMNT, and (E,E)-4,8,12-trimethyltrideca-1,3,7,11-tetraene, TMTT, are volatile homoterpenes. Many such volatiles are assigned functions in the defense against pathogens like lepidopteran larvae, aphids, fungi,and bacteria. Maize volatiles released after herbivore damage display high levels of quantitative and qualitative variation. In planta, DMNT is primarily produced by CYP92C5, whereas the majority of TMTT is produced by a related cytochrome P450 monooxygenase, CYP92C6, which is specific for the conversion of (E,E)-geranyllinalool to TMTT
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Lee, S.; Badieyan, S.; Bevan, D.R.; Herde, M.; Gatz, C.; Tholl, D.
Herbivore-induced and floral homoterpene volatiles are biosynthesized by a single P450 enzyme (CYP82G1) in Arabidopsis
Proc. Natl. Acad. Sci. USA
107
21205-21210
2010
Arabidopsis thaliana (Q9LSF8)
brenda
Tholl, D.; Sohrabi, R.; Huh, J.; Lee, S.
The biochemistry of homoterpenes - Common constituents of floral and herbivore-induced plant volatile bouquets
Phytochemistry
72
1635-1646
2011
Arabidopsis thaliana
brenda
Sohrabi, R.; Huh, J.; Badieyan, S.; Rakotondraibe, L.; Kliebenstein, D.; Sobrado, P.; Tholl, D.
In planta variation of volatile biosynthesis an alternative biosynthetic route to the formation of the pathogen-induced volatile homoterpene DMNT via triterpene degradation in Arabidopsis roots
Plant Cell
27
874-890
2015
Arabidopsis thaliana, Arabidopsis thaliana (B0T7D7)
brenda
Richter, A.; Schaff, C.; Zhang, Z.; Lipka, A.; Tian, F.; Koellner, T.; Schnee, C.; Preiss, S.; Irmisch, S.; Jander, G.; Boland, W.; Gershenzon, J.; Buckler, E.; Degenhardt, J.
Characterization of biosynthetic pathways for the production of the volatile homoterpenes DMNT and TMTT in Zea mays
Plant Cell
28
2651-2665
2016
Zea mays, Zea mays (B6ST66), Zea mays (B8A110)
brenda
Lee, S.; Badieyan, S.; Bevan, D.R.; Herde, M.; Gatz, C.; Tholl, D.
Herbivore-induced and floral homoterpene volatiles are biosynthesized by a single P450 enzyme (CYP82G1) in Arabidopsis
Proc. Natl. Acad. Sci. USA
107
21205-21210
2010
Arabidopsis thaliana (Q9LSF8)
brenda